Clinical Trials Browser

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT05859971 2025-07-29

ICG and SLN Mapping

Phase EARLY_PHASE1 Completed

10 enrolled 7 charts

Breast

Breast Neoplasms

NCT06246786 2025-07-16

Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

Phase EARLY_PHASE1 Withdrawn

Breast

Triple Negative Breast Neoplasms

NCT06411678 2025-06-17

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

Phase EARLY_PHASE1 Recruiting

50 enrolled

Breast

Breast Neoplasms

NCT07023848 2025-06-17

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

Phase EARLY_PHASE1 Enrolling by invitation

10 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT07023861 2025-06-17

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

Phase EARLY_PHASE1 Enrolling by invitation

20 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT04674306 2025-05-23

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

35 enrolled

Breast

Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT05464810 2025-05-23

Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer

Phase EARLY_PHASE1 Recruiting

40 enrolled

Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT04648904 2025-05-22

Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

71 enrolled

Breast

Invasive Breast Cancer

NCT06145399 2025-05-18

A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer

Phase EARLY_PHASE1 Withdrawn

Breast

Breast Neoplasms

NCT03685175 2025-03-30

HPCardiotox

Phase EARLY_PHASE1 Completed

79 enrolled

Breast

Breast Neoplasms

NCT06637306 2025-03-26

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

Phase EARLY_PHASE1 Recruiting

15 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06756295 2025-03-12

FAST-CR

Phase EARLY_PHASE1 Not yet recruiting

154 enrolled

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT02872025 2025-01-30

Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)

Phase EARLY_PHASE1 Active not recruiting

42 enrolled

Breast

Carcinoma, Intraductal, Noninfiltrating

NCT03473691 2024-12-09

Breast50

Phase EARLY_PHASE1 Withdrawn

Breast

Triple Negative Breast Neoplasms

NCT04674722 2024-12-09

HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody

Phase EARLY_PHASE1 Completed

43 enrolled

Breast

Breast Neoplasms

NCT03832985 2024-11-05

Pediatric Reporting of Adult-Onset Genomic Results

Phase EARLY_PHASE1 Completed

427 enrolled

BreastGastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Hyperlipoproteinemia Type II, Hereditary Breast and Ovarian Cancer Syndrome

NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

Phase EARLY_PHASE1 Completed

10 enrolled

Breast

Breast Neoplasms

NCT03962647 2024-10-15

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Phase EARLY_PHASE1 Completed

31 enrolled

Breast

Estrogen Receptor-positive Breast Cancer

Clinical Trials

BreastMRgFUS

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

FES BPET-DBT in Newly Diagnosed Breast Cancer

Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)

WINIT-BC

Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC

Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

B-GLUCANCER2

Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity

Window of Opportunity Study Targeting the Inflammatory Milieu

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness

OU-SCC-NCAN

Mirtazapine for Acute and Chronic Post Mastectomy Pain

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.

3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer

FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer

MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Comparison of CE-DBT and MRI in Patients With Known Breast Lesions

PROMETEO

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

ICG and SLN Mapping

Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer

Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer

A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer

HPCardiotox

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

FAST-CR

Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)

Breast50

HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody

Pediatric Reporting of Adult-Onset Genomic Results

RANKL Inhibition and Breast Tissue Biomarkers

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer